Pain Outcomes During Rigid Cystoscopy in Females With and Without Cystoscopic Sheath Obturator
Launched by TODD MOYERBRAILEAN DO FACOG · Dec 7, 2021
Trial Information
Current as of May 12, 2025
Terminated
Keywords
ClinConnect Summary
Rigid cystoscopy is a common procedure to evaluate lower urinary tract symptoms in females. This procedure can be done with or without an instrument called a sheath obturator (or obturator for short). There are two acceptable insertion techniques for performing cystoscopy in women. Surgeons can perform cystoscope without the use of the obturator by using a "visual" technique where a telescope with a sheath is inserted for entry into the bladder (referred to as cystoscopy without the obturator). Surgeons can also perform cystoscopy by using an obturator with a sheath allowing for smooth entr...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Female patients scheduled for gynecological procedures where cystoscopy is indicated
- • Ability to comprehend and participate in the study
- Exclusion Criteria:
- • \< 18 years
- • Pregnancy
- • Current pelvic mesh erosion
- • Exposure or pain complications from mesh
- • Genitourinary malignancy;
- • History of recurrent urinary tract infection (e.g., 2 in 6 months)
About Todd Moyerbrailean Do Facog
Dr. Todd Moyer-Brailean, DO, FACOG, is a distinguished clinical trial sponsor with extensive expertise in obstetrics and gynecology. Committed to advancing women's health, Dr. Moyer-Brailean leads innovative research initiatives aimed at improving clinical outcomes and enhancing patient care. His dedication to evidence-based practices and rigorous scientific inquiry positions him as a key contributor to the development of new therapies and interventions in the field. With a focus on collaboration and ethical research standards, Dr. Moyer-Brailean is dedicated to fostering advancements that benefit both patients and the broader medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
East Lansing, Michigan, United States
Patients applied
Trial Officials
Todd Moyerbrailean, DO, FACOG
Principal Investigator
Michigan State University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials